keyword
https://read.qxmd.com/read/38273871/marburg-virus-outbreak-in-equatorial-guinea-need-for-speed
#21
JOURNAL ARTICLE
Kengo Nathan Ezie, Berjo Dongmo Takoutsing, Diele Modeste, Miste Zourmba Ines, Tatsadjieu Ngoune Leopoldine Sybile, Nformi Monde Caleb, Ignatius N Esene
The co-existence of deadly viral pandemics can be considered a nightmare for public health authorities. The surge of a Marburg virus disease (MVD) outbreak in Africa at a time when the coronavirus-19 (COVID-19) pandemic is partially controlled with its limited resources is an urgent call for concern. Over the past decades, several bouts of MVD outbreaks have occurred in Africa with an alarming case fatality rate. Despite this, little has been done to end its recurrence, and affected countries essentially depend on preventative rather than curative measures of management...
2024: Annals of Global Health
https://read.qxmd.com/read/38270432/exploring-plant-derived-small-molecules-as-inhibitors-of-marburg-virus-rna-binding-protein-activity
#22
JOURNAL ARTICLE
Leena Hussein Bajrai, Abdulrahman Abdullah Almalki, Amaresh Kumar Sahoo, Vivek Dhar Dwivedi, Esam Ibraheem Azhar
The search for antiviral medications is greatly influenced by the hunt for potent inhibitors of viral proteins. To find possible inhibitors of the RNA binding activity of the Marburg virus VP35 protein, we used a thorough in silico drug discovery approach in this investigation. A comprehensive virtual screening process, followed by a detailed MMGBSA analysis, led to the discovery of four potential inhibitory compounds viz. Kudzuisoflavone A, Miquelianin, Rutin, and Protopseudohypericin. They were identified from an extensive library of phytomolecules derived from three medicinal plants: Adiantum capillus-veneris , Hypericum perforatum , and Pueraria montana ...
January 25, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38248659/structural-and-dynamical-basis-of-vp35-rbd-inhibition-by-marine-fungi-compounds-to-combat-marburg-virus-infection
#23
JOURNAL ARTICLE
Abdullah S Alawam, Hadil Sultan Alawam, Mohammed Merae Alshahrani, Maher S Alwethaynani, Lina M Alneghery, Mubarak A Alamri
The Marburg virus (MBV), a deadly pathogen, poses a serious threat to world health due to the lack of effective treatments, calling for an immediate search for targeted and efficient treatments. In this study, we focused on compounds originating from marine fungi in order to identify possible inhibitory compounds against the Marburg virus (MBV) VP35-RNA binding domain (VP35-RBD) using a computational approach. We started with a virtual screening procedure using the Lipinski filter as a guide. Based on their docking scores, 42 potential candidates were found...
January 3, 2024: Marine Drugs
https://read.qxmd.com/read/38234048/application-of-temperature-dependent-and-steered-molecular-dynamics-simulation-to-screen-anti-dengue-compounds-against-marburg-virus
#24
JOURNAL ARTICLE
Ali A Rabaan, Zainab H Almansour, Ali Al Bshabshe, Muhammad A Halwani, Maha F Al-Subaie, Nawal A Al Kaabi, Saleh A Alshamrani, Ahmad A Alshehri, Mohammed H Nahari, Ali S Alqahtani, Mashael Alhajri, Mohammed Alissa
Marburg virus infections are extremely fatal with a fatality range of 23% to 90%, therefore there is an urgent requirement to design and develop efficient therapeutic molecules. Here, a comprehensive temperature-dependent molecular dynamics (MD) simulation method was implemented to identify the potential molecule from the anti-dengue compound library that can inhibit the function of the VP24 protein of Marburg. Virtual high throughput screening identified five effective binders of VP24 after screening 484 anti-dengue compounds...
January 17, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38178383/identification-of-novel-inhibitors-against-vp40-protein-of-marburg-virus-by-integrating-molecular-modeling-and-dynamics-approaches
#25
JOURNAL ARTICLE
Muhammad Saeed, Mubarak A Alamri, Muhammad Abdul Rehman Rashid, Muhammad Rizwan Javed, Farrukh Azeem, Zarmina Bashir, Abdullah R Alanzi, Ziyad Tariq Muhseen, Shahad Youseff Almusallam, Khadim Hussain
Marburg virus (MV) is a highly etiological agent of haemorrhagic fever in humans and has spread across the world. Its outbreaks caused a 23-90% human death rate. However, there are currently no authorized preventive or curative measures yet. VP40 is the MV matrix protein, which builds protein shell underneath the viral envelope and confers hallmark filamentous. VP40 alone is able to induce assembly and budding of filamentous virus-like particles (VLPs), which resemble authentic virions. As a result, this research is credited with clarifying the function of VP40 and leading to the discovery of new therapeutic targets effective in combating MV disease (MVD)...
January 4, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38158300/thermostable-bivalent-filovirus-vaccine-protects-against-severe-and-lethal-sudan-ebolavirus-and-marburgvirus-infection
#26
JOURNAL ARTICLE
Albert To, Teri Ann S Wong, Aquena H Ball, Michael M Lieberman, Jake Yalley-Ogunro, Mehtap Cabus, Sara Nezami, Fabian Paz, Hanne Andersen Elyard, Viktoriya Borisevich, Krystle N Agans, Daniel J Deer, Courtney Woolsey, Robert W Cross, Thomas W Geisbert, Oreola Donini, Axel T Lehrer
Although two vaccines for Zaire ebolavirus (EBOV) have been licensed and deployed successfully to combat recurring outbreaks of Ebolavirus Disease in West Africa, there are no vaccines for two other highly pathogenic members of the Filoviridae, Sudan ebolavirus (SUDV) and Marburg marburgvirus (MARV). The results described herein document the immunogenicity and protective efficacy in cynomolgus macaques of a single-vial, thermostabilized (lyophilized) monovalent (SUDV) and bivalent (SUDV & MARV) protein vaccines consisting of recombinant glycoproteins (GP) formulated with a clinical-grade oil-in-water nanoemulsion adjuvant (CoVaccine HT™)...
December 28, 2023: Vaccine
https://read.qxmd.com/read/38156576/markers-of-antroponotic-viral-infections-in-vervet-monkeys-arrived-from-their-natural-habitat-tanzania
#27
JOURNAL ARTICLE
D I Dogadov, K K Kyuregyan, G M Alexandra, A A Minosyan, A A Kochkonyan, A A Karlsen, O I Vyshemirsky, D D Karal-Ogly, M I Mikhailov
INTRODUCTION: Various human viruses have been identified in wild monkeys and in captive primates. Cases of transmission of viruses from wild monkeys to humans and vice versa are known. The aim of this study was to identify markers of anthroponotic viral infections in vervet monkeys ( Chlorocebus pygerythrus ) arrived from their natural habitat (Tanzania). MATERIALS AND METHODS: Fecal samples ( n = 56) and blood serum samples ( n = 75) obtained from 75 animals, respectively, on days 10 and 23 after admission to the primate center, were tested for the markers of anthroponotic viral infections (Ebola virus, Marburg virus, lymphocytic choriomeningitis, hepatitis C virus, herpes simplex virus (HSV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), parainfluenza types 1 and 3, intestinal adenoviruses, rotaviruses) by enzyme immunoassay (ELISA) and polymerase chain reaction (PCR)...
November 7, 2023: Voprosy Virusologii
https://read.qxmd.com/read/38140590/development-of-an-immunochromatography-assay-to-detect-marburg-virus-and-ravn-virus
#28
JOURNAL ARTICLE
Katendi Changula, Masahiro Kajihara, Shino Muramatsu, Koji Hiraoka, Toru Yamaguchi, Yoko Yago, Daisuke Kato, Hiroko Miyamoto, Akina Mori-Kajihara, Asako Shigeno, Reiko Yoshida, Corey W Henderson, Andrea Marzi, Ayato Takada
The recent outbreaks of Marburg virus disease (MVD) in Guinea, Ghana, Equatorial Guinea, and Tanzania, none of which had reported previous outbreaks, imply increasing risks of spillover of the causative viruses, Marburg virus (MARV) and Ravn virus (RAVV), from their natural host animals. These outbreaks have emphasized the need for the development of rapid diagnostic tests for this disease. Using monoclonal antibodies specific to the viral nucleoprotein, we developed an immunochromatography (IC) assay for the rapid diagnosis of MVD...
November 29, 2023: Viruses
https://read.qxmd.com/read/38140576/characterization-of-the-cynomolgus-macaque-model-of-marburg-virus-disease-and-assessment-of-timing-for-therapeutic-treatment-testing
#29
JOURNAL ARTICLE
Elizabeth E Zumbrun, Carly B Garvey, Jay B Wells, Ginger C Lynn, Sean Van Tongeren, Jesse T Steffens, Kelly S Wetzel, Laura M Gomba, Kristan A O'Brien, Franco D Rossi, Xiankun Zeng, Eric D Lee, Jo Lynne W Raymond, Diana A Hoffman, Alexandra N Jay, Elizabeth S Brown, Paul A Kallgren, Sarah L Norris, Jean Cantey-Kiser, Humza Kudiya, Chris Arthur, Christiana Blair, Darius Babusis, Victor C Chu, Bali Singh, Roy Bannister, Danielle P Porter, Tomas Cihlar, John M Dye
Marburg virus (MARV) causes severe disease and high mortality in humans. The objective of this study was to characterize disease manifestations and pathogenesis in cynomolgus macaques exposed to MARV. The results of this natural history study may be used to identify features of MARV disease useful in defining the ideal treatment initiation time for subsequent evaluations of investigational therapeutics using this model. Twelve cynomolgus macaques were exposed to a target dose of 1000 plaque-forming units MARV by the intramuscular route, and six control animals were mock-exposed...
November 28, 2023: Viruses
https://read.qxmd.com/read/38106901/serological-evidence-of-virus-infection-in-eidolon-helvum-fruit-bats-implications-for-bushmeat-consumption-in-nigeria
#30
JOURNAL ARTICLE
Diego Cantoni, Martin Mayora-Neto, Mariliza Derveni, Kelly da Costa, Joanne Del Rosario, Veronica O Ameh, Claude T Sabeta, Bethany Auld, Arran Hamlet, Ian M Jones, Edward Wright, Simon D Scott, Efstathios S Giotis, Ashley C Banyard, Nigel Temperton
INTRODUCTION: The Eidolon helvum fruit bat is one of the most widely distributed fruit bats in Africa and known to be a reservoir for several pathogenic viruses that can cause disease in animals and humans. To assess the risk of zoonotic spillover, we conducted a serological survey of 304 serum samples from E. helvum bats that were captured for human consumption in Makurdi, Nigeria. METHODS: Using pseudotyped viruses, we screened 304 serum samples for neutralizing antibodies against viruses from the Coronaviridae, Filoviridae, Orthomyxoviridae and Paramyxoviridae families...
2023: Frontiers in Public Health
https://read.qxmd.com/read/38102147/author-correction-a-nonlinear-fractional-epidemic-model-for-the-marburg-virus-transmission-with-public-health-education
#31
Emmanuel Addai, Adejimi Adeniji, Mercy Ngungu, Godfred Kuffuor Tawiah, Edmore Marinda, Joshua Kiddy K Asamoah, Muhammad Altaf Khan
No abstract text is available yet for this article.
December 15, 2023: Scientific Reports
https://read.qxmd.com/read/38064023/reverse-genetics-systems-for-filoviruses
#32
JOURNAL ARTICLE
Bianca S Bodmer, Thomas Hoenen
Filoviruses are causative agents of severe hemorrhagic fevers with high case fatality rates in humans. For studies of virus biology and the subsequent development of countermeasures, reverse genetic systems, and especially those facilitating the generation of recombinant filoviruses, are indispensable. Here, we describe the generation of recombinant filoviruses from cDNA.
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38040006/marburg-virus-disease-outbreaks-mathematical-models-and-disease-parameters-a-systematic-review
#33
REVIEW
Gina Cuomo-Dannenburg, Kelly McCain, Ruth McCabe, H Juliette T Unwin, Patrick Doohan, Rebecca K Nash, Joseph T Hicks, Kelly Charniga, Cyril Geismar, Ben Lambert, Dariya Nikitin, Janetta Skarp, Jack Wardle, Mara Kont, Sangeeta Bhatia, Natsuko Imai, Sabine van Elsland, Anne Cori, Christian Morgenstern
The 2023 Marburg virus disease outbreaks in Equatorial Guinea and Tanzania highlighted the importance of better understanding this lethal pathogen. We did a systematic review (PROSPERO CRD42023393345) of peer-reviewed articles reporting historical outbreaks, modelling studies, and epidemiological parameters focused on Marburg virus disease. We searched PubMed and Web of Science from database inception to March 31, 2023. Two reviewers evaluated all titles and abstracts with consensus-based decision making. To ensure agreement, 13 (31%) of 42 studies were double-extracted and a custom-designed quality assessment questionnaire was used for risk of bias assessment...
November 28, 2023: Lancet Infectious Diseases
https://read.qxmd.com/read/38036303/design-synthesis%C3%A2-and-antiviral-evaluation-of-novel-conjugates-of-the-1-7-7-trimethylbicyclo-2-2-1-heptane-scaffold-and-saturated-n-heterocycles-via-1-2-3-triazole-linker
#34
JOURNAL ARTICLE
Anastasiya S Sokolova, Olga I Yarovaya, Oleg I Artyushin, Elena V Sharova, Dmitriy S Baev, Ekaterina D Mordvinova, Dmitriy N Shcherbakov, Tatiana A Shnaider, Tatiana V Nikitina, Iana L Esaulkova, Polina A Ilyina, Vladimir V Zarubaev, Valery K Brel, Tatyana G Tolstikova, Nariman F Salakhutdinov
A new series of heterocyclic derivatives with a 1,7,7-trimethylbicyclo[2.2.1]heptane fragment was designed, synthesised and biologically evaluated. Synthesis of the target compounds was performed using the Cu(I) catalysed cycloaddition reaction. The key starting substances in the click reaction were an alkyne containing a 1,7,7-trimethylbicyclo[2.2.1]heptane fragment and a series of azides with saturated nitrogen-containing heterocycles. Some of the derivatives were found to exhibit strong antiviral activity against Marburg and Ebola pseudotype viruses...
November 30, 2023: Archiv der Pharmazie
https://read.qxmd.com/read/38012426/designing-a-novel-and-combinatorial-multi-antigenic-epitope-based-vaccine-marvax-against-marburg-virus-a-reverse-vaccinology-and-immunoinformatics-approach
#35
JOURNAL ARTICLE
Bishal Debroy, Sribas Chowdhury, Kuntal Pal
CONTEXT: Marburg virus (MARV) is a member of the Filoviridae family and causes Marburg virus disease (MVD) among humans and primates. With fatality rates going up to 88%, there is currently no commercialized cure or vaccine to combat the infection. The National Institute of Allergy and Infectious Diseases (NIAID) classified MARV as priority pathogen A, which presages the need for a vaccine candidate which can provide stable, long-term adaptive immunity. The surface glycoprotein (GP) and fusion protein (FP) mediate the adherence, fusion, and entry of the virus into the host cell via the TIM-I receptor...
November 28, 2023: Journal, Genetic Engineering & Biotechnology
https://read.qxmd.com/read/37995774/functional-characterization-of-af-04-an-afucosylated-anti-marv-gp-antibody
#36
REVIEW
Min Zhang, Yuting Zhang, Haiyan Wu, Xinwei Wang, Hang Zheng, Junjuan Feng, Jing Wang, Longlong Luo, He Xiao, Chunxia Qiao, Xinying Li, Yuanqiang Zheng, Weijin Huang, Youchun Wang, Yi Wang, Yanchun Shi, Jiannan Feng, Guojiang Chen
Marburg virus (MARV), one member of the Filoviridae family, cause sporadic outbreaks of hemorrhagic fever with high mortality rates. No countermeasures are currently available for the prevention or treatment of MARV infection. Monoclonal antibodies (mAbs) are promising candidates to display high neutralizing activity against MARV infection in vitro and in vivo. Recently, growing evidence has shown that immune effector function including antibody-dependent cell-mediated cytotoxicity (ADCC) is also required for in vivo efficacy of a panel of antibodies...
November 21, 2023: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/37964296/a-mathematical-model-of-marburg-virus-disease-outbreaks-and-the-potential-role-of-vaccination-in-control
#37
JOURNAL ARTICLE
George Y Qian, W John Edmunds, Daniel G Bausch, Thibaut Jombart
BACKGROUND: Marburg virus disease is an acute haemorrhagic fever caused by Marburg virus. Marburg virus is zoonotic, maintained in nature in Egyptian fruit bats, with occasional spillover infections into humans and nonhuman primates. Although rare, sporadic cases and outbreaks occur in Africa, usually associated with exposure to bats in mines or caves, and sometimes with secondary human-to-human transmission. Outbreaks outside of Africa have also occurred due to importation of infected monkeys...
November 14, 2023: BMC Medicine
https://read.qxmd.com/read/37935815/a-nonlinear-fractional-epidemic-model-for-the-marburg-virus-transmission-with-public-health-education
#38
JOURNAL ARTICLE
Emmanuel Addai, Adejimi Adeniji, Mercy Ngungu, Godfred Kuffuor Tawiah, Edmore Marinda, Joshua Kiddy K Asamoah, Mohammed Altaf Khan
In this study, a deterministic model for the dynamics of Marburg virus transmission that incorporates the impact of public health education is being formulated and analyzed. The Caputo fractional-order derivative is used to extend the traditional integer model to a fractional-based model. The model's positivity and boundedness are also under investigation. We obtain the basic reproduction number [Formula: see text] and establish the conditions for the local and global asymptotic stability for the disease-free equilibrium of the model...
November 7, 2023: Scientific Reports
https://read.qxmd.com/read/37925643/exploration-of-phytochemical-compounds-against-marburg-virus-using-qsar-molecular-dynamics-and-free-energy-landscape
#39
JOURNAL ARTICLE
Ali A Rabaan, Muhammad A Halwani, Mohammed Garout, Jawaher Alotaibi, Bashayer M AlShehail, Nouf Alotaibi, Souad A Almuthree, Ahmad A Alshehri, Mohammed Abdulrahman Alshahrani, Basim Othman, Abdulaziz Alqahtani, Mohammed Alissa
Marburg virus disease (MVD) is caused by the Marburg virus, a one-of-a-kind zoonotic RNA virus from the genus Filovirus. Thus, this current study employed AI-based QSAR and molecular docking-based virtual screening for identifying potential binders against the target protein (nucleoprotein (NP)) of the Marburg virus. A total of 2727 phytochemicals were used for screening, out of which the top three compounds (74977521, 90470472, and 11953909) were identified based on their predicted bioactivity (pIC50) and binding score (< - 7...
November 5, 2023: Molecular Diversity
https://read.qxmd.com/read/37918428/-ebola-and-marburg-virus-disease
#40
JOURNAL ARTICLE
Stefan Schmiedel, Timo Wolf
Viral hemorrhagic fevers (VHF) are serious, often fatal diseases that affect humans and non-human primates. The nomenclature of these diseases has changed in that they are now referred to as viral diseases because the previously named symptoms of fever or hemorrhages are not obligatory. In this article, the focus will be on the VHFs Ebola and Marburg viral disease with the potential for human-to-human transmission; these diseases are so-called high-consequence infectious diseases (HCID), some with considerable potential for epidemic spread and the risk of nosocomial transmission...
November 2023: Deutsche Medizinische Wochenschrift
keyword
keyword
41123
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.